MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review
Reference Code: GDPH82376FSA Publication Date: APR 2012
Tour 5 GIGA niveau +3, Av. de
Phone +32 4 3642070 Revenue 2.50 (million EUR)
l'Hopital 11
LIEGE, Liege Fax +32 4 3642071 Net Profit -8.25 (million EUR)
4000 Website www.mdxhealth.com Employees 37
MDXH [Euronext Pharmaceuticals &
Belgium Exchange Industry
Brussels] Healthcare
Company Overview
MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. The company develops
and commercializes advanced molecular diagnostic tests for early cancer detection and personalized treatment decisions. It
focuses mainly on three different types of cancers, namely, prostate cancer, colorectal cancer and lung cancer. The company's
tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides
indications of cancer recurrence and prediction of response to a specific therapy. The company's product line includes molecular
diagnostics, clinical diagnostics, and pharmaco diagnostics.
Key Executives SWOT Analysis
Name Title MDxHealth SA, SWOT Analysis
Dr. Jan Groen, Ph.D. Chief Executive Officer Strengths Weaknesses
Edward L. Erickson Chairman
Product Portfolio Cost Control
Mark Myslinski Director
Technological Capabilities
Raphael Wisniewski Director
Rudi Marien Director
Source: Annual Report, Company Website, Primary and Secondary
Opportunities Threats
Research, GlobalData
Key Business Initiatives Uncertainties in R&D
Share Data
Market Potential: Oncology Highly Competitive Industry
MDxHealth SA
Share Price (EUR) as on 13-Apr- 1.67
2012 Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
EPS (EUR) -0.63
Market Cap (million EUR) 32
Enterprise Value (million EUR) 17
Shares Outstanding (million) 19
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Financial Performance Recent Developments
Mar 15, 2012 MDxHealth Reports Revenue Of €2.7m In
2011
Jan 22, 2012 MDxHealth Receives CLIA Certification And
California State License For Its Clinical
Laboratory
Dec 14, 2011 Meta-Analysis Confirms Link Between
Epigenetic Changes And Prostate Cancer,
Reports MDxHealth
Aug 25, 2011 MdxHealth Reports Total Revenues Of €1.4m
In H1 2011
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Reference Code: GDPH82376FSA
Review
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 4
Section 1 - About the Company.......................................................................................................................................................... 5
MDxHealth SA - Key Facts ................................................................................................................................................................. 5
MDxHealth SA - Key Employees ........................................................................................................................................................ 6
MDxHealth SA - Key Employee Biographies ...................................................................................................................................... 7
MDxHealth SA - Major Products and Services ................................................................................................................................... 8
MDxHealth SA - Medical Equipment Pipeline Products Data ............................................................................................................. 9
MDxHealth SA Pipeline Products by Equipment Type .................................................................................................................... 9
MDxHealth SA Pipeline Products by Development Stage ............................................................................................................ 11
MDxHealth SA - History.................................................................................................................................................................... 13
MDxHealth SA - Locations And Subsidiaries.................................................................................................................................... 15
Head Office ................................................................................................................................................................................... 15
Other Locations & Subsidiaries ..................................................................................................................................................... 15
Section 2 – Company Analysis ......................................................................................................................................................... 16
MDxHealth SA - Business Description ............................................................................................................................................. 16
MDxHealth SA - Corporate Strategy ................................................................................................................................................ 17
MDxHealth SA - SWOT Analysis...................................................................................................................................................... 18
SWOT Analysis - Overview........................................................................................................................................................... 18
MDxHealth SA - Strengths ............................................................................................................................................................ 18
Strength - Product Portfolio ....................................................................................................................................................... 18
Strength - Technological Capabilities ........................................................................................................................................ 18
Strength - Partnerships and Collaborations............................................................................................................................... 18
MDxHealth SA - Weaknesses....................................................................................................................................................... 19
Weakness - Cost Control .......................................................................................................................................................... 19
MDxHealth SA - Opportunities ...................................................................................................................................................... 19
Opportunity - Key Business Initiatives ....................................................................................................................................... 19
Opportunity - Market Potential: Oncology.................................................................................................................................. 19
Opportunity - Demographics Trends ......................................................................................................................................... 20
MDxHealth SA - Threats ............................................................................................................................................................... 20
Threat - Uncertainties in R&D ................................................................................................................................................... 20
Threat - Highly Competitive Industry ......................................................................................................................................... 20
Threat - Stringent Government Regulations .............................................................................................................................. 20
MDxHealth SA - Key Competitors .................................................................................................................................................... 22
Section 3 – Company Financial Ratios ............................................................................................................................................. 23
Financial Ratios - Capital Market Ratios........................................................................................................................................... 23
Financial Ratios - Annual Ratios ...................................................................................................................................................... 23
Performance Chart ........................................................................................................................................................................... 25
Financial Performance...................................................................................................................................................................... 25
Financial Ratios - Interim Ratios....................................................................................................................................................... 26
Financial Ratios - Ratio Charts ......................................................................................................................................................... 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 28
MDxHealth SA, Medical Equipment, Deals By Year, 2006 to YTD 2012 ...................................................................................... 28
MDxHealth SA, Medical Equipment, Deals By Type, 2006 to YTD 2012 ...................................................................................... 29
MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Reference Code: GDPH82376FSA
Review
Source : www.globalcompanyintelligence.com Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 .................................................................... 30
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 .................................................................... 31
MDxHealth SA, Recent Deals Summary .................................................................................